| RS587777271 |
CPOX
|
Health Risk |
Pathogenic |
Harderoporphyria, Harderoporphyria |
| RS587777272 |
SLC7A14
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 68, Retinitis pigmentosa 68 |
| RS587777273 |
SLC7A14
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 68, Retinitis pigmentosa 68 |
| RS587777274 |
NR2F1
|
Health Risk |
Pathogenic |
Bosch-Boonstra-Schaaf optic atrophy syndrome, Bosch-Boonstra-Schaaf optic atrophy syndrome |
| RS587777275 |
NR2F1
|
Health Risk |
Pathogenic |
Bosch-Boonstra-Schaaf optic atrophy syndrome, Bosch-Boonstra-Schaaf optic atrophy syndrome |
| RS587777276 |
NR2F1
|
Health Risk |
Likely pathogenic |
Bosch-Boonstra-Schaaf optic atrophy syndrome, Bosch-Boonstra-Schaaf optic atrophy syndrome |
| RS587777277 |
NR2F1
|
Health Risk |
Likely pathogenic |
Bosch-Boonstra-Schaaf optic atrophy syndrome, Bosch-Boonstra-Schaaf optic atrophy syndrome |
| RS587777278 |
BCS1L
|
Health Risk |
Pathogenic |
Pili torti-deafness syndrome, Pili torti-deafness syndrome |
| RS587777279 |
ITGA8
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal hypodysplasia/aplasia 1, Renal hypodysplasia/aplasia 1 |
| RS587777280 |
ITGA8
|
Health Risk |
Pathogenic |
Renal hypodysplasia/aplasia 1, Renal hypodysplasia/aplasia 1 |
| RS587777282 |
FGF20
|
Health Risk |
Pathogenic |
Renal hypodysplasia/aplasia 2, Renal hypodysplasia/aplasia 2 |
| RS587777283 |
TSPAN12
|
Health Risk |
Pathogenic/Likely pathogenic |
Exudative vitreoretinopathy 5, Exudative vitreoretinopathy 5 |
| RS587777284 |
TSPAN12
|
Health Risk |
Pathogenic |
Exudative vitreoretinopathy 5, Exudative vitreoretinopathy 5 |
| RS587777285 |
TSPAN12
|
Health Risk |
Pathogenic |
Exudative vitreoretinopathy 5, Exudative vitreoretinopathy 5 |
| RS587777286 |
SLC25A20
|
Health Risk |
Pathogenic |
Carnitine acylcarnitine translocase deficiency, Carnitine acylcarnitine translocase deficiency |
| RS587777287 |
SLC25A20
|
Health Risk |
Pathogenic |
Carnitine acylcarnitine translocase deficiency, Carnitine acylcarnitine translocase deficiency |
| RS587777288 |
GSC
|
Health Risk |
Pathogenic |
Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome, Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome |
| RS587777289 |
GSC
|
Health Risk |
Pathogenic |
Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome, Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome |
| RS587777290 |
GSC
|
Health Risk |
Pathogenic |
Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome, Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome |
| RS587777292 |
KRT6C
|
Health Risk |
Pathogenic/Likely pathogenic |
Palmoplantar keratoderma, nonepidermolytic |
| RS587777293 |
POGLUT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Dowling-Degos disease 4, Dowling-Degos disease 4 |
| RS587777294 |
POGLUT1
|
Health Risk |
Pathogenic |
Dowling-Degos disease 4, Dowling-Degos disease 4 |
| RS587777295 |
POGLUT1
|
Health Risk |
Pathogenic |
Dowling-Degos disease 4, Dowling-Degos disease 4 |
| RS587777296 |
POGLUT1
|
Health Risk |
Pathogenic |
Dowling-Degos disease 4, Dowling-Degos disease 4 |
| RS587777298 |
AGRN
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome |
| RS587777299 |
AGRN
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome |
| RS587777303 |
TBXT
|
Health Risk |
Pathogenic |
Sacral agenesis-abnormal ossification of the vertebral bodies-persistent notochordal canal syndrome, Sacral agenesis-abnormal ossification of the vertebral bodies-persistent notochordal canal syndrome |
| RS587777305 |
MBTPS2
|
Health Risk |
Pathogenic |
IFAP syndrome 1, with or without BRESHECK syndrome |
| RS587777306 |
MBTPS2
|
Health Risk |
Pathogenic |
Olmsted syndrome, X-linked |
| RS587777307 |
GABRA1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 19 |
| RS587777308 |
GABRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 19 |
| RS587777309 |
GABRA1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 19 |
| RS587777310 |
STXBP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS587777312 |
ADGRG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polymicrogyria, bilateral perisylvian |
| RS587777314 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS587777315 |
SPG21
|
Health Risk |
Pathogenic |
Mast syndrome, Mast syndrome |
| RS587777316 |
CA5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency, Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency |
| RS587777317 |
USP9X
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 99 |
| RS587777318 |
USP9X
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 99 |
| RS587777320 |
GUCY1A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Moyamoya disease with early-onset achalasia, Moyamoya disease with early-onset achalasia |
| RS587777321 |
GUCY1A1
|
Health Risk |
Pathogenic |
Moyamoya disease with early-onset achalasia, Moyamoya disease with early-onset achalasia |
| RS587777322 |
GUCY1A1
|
Health Risk |
Pathogenic |
Moyamoya disease with early-onset achalasia, Moyamoya disease with early-onset achalasia |
| RS587777323 |
MOGS
|
Health Risk |
Pathogenic |
MOGS-congenital disorder of glycosylation, MOGS-congenital disorder of glycosylation |
| RS587777325 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS587777326 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability |
| RS587777327 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Inborn genetic diseases |
| RS587777328 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS587777329 |
SETD5
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Inborn genetic diseases |
| RS587777330 |
TRAPPC2
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia tarda, Spondyloepiphyseal dysplasia tarda |
| RS587777331 |
QARS1
|
Health Risk |
Pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, QARS1-related disorder |
| RS587777332 |
QARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS587777333 |
QARS1
|
Health Risk |
Likely pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS587777334 |
QARS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Intellectual disability |
| RS587777335 |
LCK
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to LCK deficiency, Severe combined immunodeficiency due to LCK deficiency |
| RS587777336 |
KCNA5
|
Health Risk |
Pathogenic |
Atrial fibrillation, familial |
| RS587777337 |
MALT1
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to MALT1 deficiency, Combined immunodeficiency due to MALT1 deficiency |
| RS587777338 |
IL21
|
Health Risk |
Pathogenic |
IL21-related infantile inflammatory bowel disease, IL21-related infantile inflammatory bowel disease |
| RS587777339 |
NUP155
|
Health Risk |
Pathogenic |
Atrial fibrillation, familial |
| RS587777340 |
STUB1
|
Health Risk |
Pathogenic |
Autosomal recessive spinocerebellar ataxia 16, Autosomal recessive spinocerebellar ataxia 16 |
| RS587777341 |
STUB1
|
Health Risk |
Pathogenic |
Autosomal recessive spinocerebellar ataxia 16, Autosomal recessive spinocerebellar ataxia 16 |
| RS587777342 |
STUB1
|
Health Risk |
Pathogenic |
Autosomal recessive spinocerebellar ataxia 16, Autosomal recessive spinocerebellar ataxia 16 |
| RS587777343 |
STUB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive spinocerebellar ataxia 16, Spinocerebellar ataxia 48 |
| RS587777344 |
STUB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive spinocerebellar ataxia 16, Autosomal recessive spinocerebellar ataxia 16 |
| RS587777345 |
STUB1
|
Health Risk |
Pathogenic |
Autosomal recessive spinocerebellar ataxia 16, Autosomal recessive spinocerebellar ataxia 16 |
| RS587777346 |
STUB1
|
Health Risk |
Pathogenic |
Autosomal recessive spinocerebellar ataxia 16, Autosomal recessive spinocerebellar ataxia 16 |
| RS587777347 |
STUB1
|
Health Risk |
Likely pathogenic |
Autosomal recessive spinocerebellar ataxia 16, Spinocerebellar ataxia 48 |
| RS587777348 |
WDR19
|
Health Risk |
Pathogenic |
Senior-Loken syndrome 8, Asphyxiating thoracic dystrophy 5 |
| RS587777349 |
WDR19
|
Health Risk |
Conflicting classifications of pathogenicity |
Senior-Loken syndrome 8, Asphyxiating thoracic dystrophy 5 |
| RS587777350 |
WDR19
|
Health Risk |
Pathogenic |
Nephronophthisis 13, Nephronophthisis 13 |
| RS587777351 |
WDR19
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis 13, Senior-Loken syndrome 8 |
| RS587777352 |
WDR19
|
Health Risk |
Pathogenic/Likely pathogenic |
Senior-Loken syndrome 8, Jeune thoracic dystrophy |
| RS587777354 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Alpha-actinopathy |
| RS587777355 |
TUBB
|
Health Risk |
Pathogenic |
Complex cortical dysplasia with other brain malformations 6, Inborn genetic diseases |
| RS587777356 |
TUBB
|
Health Risk |
Pathogenic/Likely pathogenic |
Complex cortical dysplasia with other brain malformations 6, TUBB-related disorder |
| RS587777357 |
TUBB
|
Health Risk |
Pathogenic |
Complex cortical dysplasia with other brain malformations 6, Inborn genetic diseases |
| RS587777358 |
ZMYM3
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder, X-linked 112 |
| RS587777359 |
DLG3
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 90 |
| RS587777360 |
DLG3
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 90 |
| RS587777361 |
GRIA3
|
Health Risk |
Pathogenic/Likely pathogenic |
Syndromic X-linked intellectual disability 94, Intellectual disability |
| RS587777362 |
ZP1
|
Health Risk |
Pathogenic |
Female infertility due to zona pellucida defect, Female infertility due to zona pellucida defect |
| RS587777363 |
GABRA1
|
Health Risk |
risk factor |
Epilepsy, idiopathic generalized |
| RS587777364 |
GABRA1
|
Health Risk |
risk factor |
Epilepsy, idiopathic generalized |
| RS587777365 |
GABRG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Febrile seizures, familial |
| RS587777366 |
XYLT1
|
Health Risk |
Pathogenic |
Desbuquois dysplasia 2, Desbuquois dysplasia 2 |
| RS587777368 |
XYLT1
|
Health Risk |
Pathogenic |
Desbuquois dysplasia 2, Desbuquois dysplasia 1 |
| RS587777369 |
XYLT1
|
Health Risk |
Pathogenic |
Desbuquois dysplasia 2, Desbuquois dysplasia 2 |
| RS587777370 |
XYLT1
|
Health Risk |
Pathogenic |
Desbuquois dysplasia 2, Desbuquois dysplasia 2 |
| RS587777371 |
NR2F2
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital heart defects, multiple types |
| RS587777372 |
NR2F2
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS587777374 |
NR2F2
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS587777375 |
GYS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease due to muscle and heart glycogen synthase deficiency, Glycogen storage disease due to muscle and heart glycogen synthase deficiency |
| RS587777376 |
KIZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 69, Retinitis pigmentosa 69 |
| RS587777377 |
KIZ
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 69, Retinal dystrophy |
| RS587777378 |
PGAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal recessive 42 |
| RS587777379 |
COL4A1
|
Health Risk |
Pathogenic |
Brain small vessel disease 1 with or without ocular anomalies, Brain small vessel disease 1 with or without ocular anomalies |
| RS587777380 |
DYRK1B
|
Health Risk |
Pathogenic |
Abdominal obesity-metabolic syndrome 3, Abdominal obesity-metabolic syndrome 3 |
| RS587777381 |
VPS13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS587777382 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Ovarian serous cystadenocarcinoma |
| RS587777383 |
ACTG2
|
Health Risk |
Likely pathogenic |
Visceral myopathy 1, Chronic intestinal pseudoobstruction |
| RS587777384 |
ACTG2
|
Health Risk |
Pathogenic |
Visceral myopathy 1, Inborn genetic diseases |